Literature DB >> 23024326

Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea.

Antonia Barceló1, Javier Piérola, Cristina Esquinas, Mónica de la Peña, Meritxell Arqué, Manuel Sánchez-de la Torre, Alberto Alonso-Fernandez, Ferran Barbé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23024326     DOI： 10.1183/09031936.00011912

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

1.  Usefulness of fetuin-A to predict risk for cardiovascular disease among patients with obstructive sleep apnea.

Authors:  Alice Liu; Cindy Lamendola; Danit Ariel; Fahim Abbasi; Sun H Kim; James Cardell; Vanessa Tomasso; Shiming Xu; Shailja Patel; Hafasa Mojaddidi; Kaylene Grove; Clete A Kushida; Gerald M Reaven
Journal:  Am J Cardiol       Date:  2015-04-18       Impact factor: 2.778

2.  Level of Serum Fetuin-A Correlates with Heart Rate in Obstructive Sleep Apnea Patients without Metabolic and Cardiovascular Comorbidities.

Authors:  Elżbieta Reichert; Jerzy Mosiewicz; Wojciech Myśliński; Andrzej Jaroszyński; Agata Stanek; Klaudia Brożyna-Tkaczyk; Barbara Madejska-Mosiewicz
Journal:  Int J Environ Res Public Health       Date:  2022-05-25       Impact factor: 4.614

3.  Salivary biomarkers indicate obstructive sleep apnea patients with cardiovascular diseases.

Authors:  Hui Zheng; Ruoxuan Li; Jieni Zhang; Shaonan Zhou; Qingwei Ma; Yanheng Zhou; Feng Chen; Jiuxiang Lin
Journal:  Sci Rep       Date:  2014-11-14       Impact factor: 4.379

Review 4.  A review of the "OMICS" for management of patients with obstructive sleep apnoea.

Authors:  Luana Conte; Marco Greco; Domenico Maurizio Toraldo; Michele Arigliani; Michele Maffia; Michele De Benedetto
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-06       Impact factor: 2.124
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.